IGC FYE2021 DEF 14A Proxy Statement - IGC Pharma, INC.

SEC

Filings

September 15, 2021

IGC FYE2021 DEF 14A Proxy Statement

Related Posts

FORM TYPE 10-Q

November 12, 2024

8K + XBRL Form 4

September 27, 2024

Richard Prins FORM 144

August 12, 2024

CEO Update

Recap of AAIC24 Conference Participation and Poster Presentations

August 28, 2024

Desk of CEO Marijuana Reclass

July 25, 2024